| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | lipid kinase activity | 1.35e-05 | 41 | 71 | 4 | GO:0001727 | |
| GeneOntologyMolecularFunction | 1-phosphatidylinositol 4-kinase activity | 7.44e-05 | 4 | 71 | 2 | GO:0004430 | |
| GeneOntologyMolecularFunction | phosphatidylinositol kinase activity | 1.06e-04 | 26 | 71 | 3 | GO:0052742 | |
| GeneOntologyMolecularFunction | testosterone 6-beta-hydroxylase activity | 1.24e-04 | 5 | 71 | 2 | GO:0050649 | |
| GeneOntologyMolecularFunction | estrogen 2-hydroxylase activity | 3.44e-04 | 8 | 71 | 2 | GO:0101021 | |
| GeneOntologyMolecularFunction | estrogen 16-alpha-hydroxylase activity | 6.72e-04 | 11 | 71 | 2 | GO:0101020 | |
| GeneOntologyMolecularFunction | ligase activity, forming carbon-nitrogen bonds | 8.88e-04 | 53 | 71 | 3 | GO:0016879 | |
| GeneOntologyBiologicalProcess | lipid modification | 7.45e-05 | 214 | 68 | 6 | GO:0030258 | |
| GeneOntologyBiologicalProcess | glycerophospholipid biosynthetic process | 8.04e-05 | 217 | 68 | 6 | GO:0046474 | |
| GeneOntologyBiologicalProcess | glycerophospholipid metabolic process | 8.73e-05 | 320 | 68 | 7 | GO:0006650 | |
| GeneOntologyBiologicalProcess | transposable element silencing by mRNA destabilization | 1.06e-04 | 5 | 68 | 2 | GO:0141008 | |
| GeneOntologyBiologicalProcess | carboxylic acid metabolic process | LPIN1 CYP3A7 RIMKLB CYP3A4 P4HA1 ASL ASNS ALDH1L1 MTHFS ELOVL6 ACOX3 FAAH2 | 1.29e-04 | 1035 | 68 | 12 | GO:0019752 |
| GeneOntologyBiologicalProcess | glutamine family amino acid metabolic process | 1.41e-04 | 80 | 68 | 4 | GO:0009064 | |
| GeneOntologyBiologicalProcess | oxoacid metabolic process | LPIN1 CYP3A7 RIMKLB CYP3A4 P4HA1 ASL ASNS ALDH1L1 MTHFS ELOVL6 ACOX3 FAAH2 | 1.58e-04 | 1058 | 68 | 12 | GO:0043436 |
| GeneOntologyBiologicalProcess | retrograde neuronal dense core vesicle transport | 1.59e-04 | 6 | 68 | 2 | GO:1990049 | |
| GeneOntologyBiologicalProcess | organic acid metabolic process | LPIN1 CYP3A7 RIMKLB CYP3A4 P4HA1 ASL ASNS ALDH1L1 MTHFS ELOVL6 ACOX3 FAAH2 | 1.67e-04 | 1064 | 68 | 12 | GO:0006082 |
| GeneOntologyBiologicalProcess | folic acid-containing compound catabolic process | 2.23e-04 | 7 | 68 | 2 | GO:0009397 | |
| GeneOntologyBiologicalProcess | pteridine-containing compound catabolic process | 2.23e-04 | 7 | 68 | 2 | GO:0042560 | |
| GeneOntologyBiologicalProcess | phosphatidic acid biosynthetic process | 2.26e-04 | 36 | 68 | 3 | GO:0006654 | |
| GeneOntologyBiologicalProcess | glycerolipid biosynthetic process | 2.54e-04 | 268 | 68 | 6 | GO:0045017 | |
| GeneOntologyBiologicalProcess | phospholipid biosynthetic process | 2.54e-04 | 268 | 68 | 6 | GO:0008654 | |
| GeneOntologyBiologicalProcess | aflatoxin metabolic process | 2.96e-04 | 8 | 68 | 2 | GO:0046222 | |
| GeneOntologyBiologicalProcess | anterograde neuronal dense core vesicle transport | 2.96e-04 | 8 | 68 | 2 | GO:1990048 | |
| GeneOntologyBiologicalProcess | mycotoxin metabolic process | 2.96e-04 | 8 | 68 | 2 | GO:0043385 | |
| GeneOntologyBiologicalProcess | organic heteropentacyclic compound metabolic process | 2.96e-04 | 8 | 68 | 2 | GO:1901376 | |
| GeneOntologyBiologicalProcess | cellular response to alkaloid | 3.10e-04 | 40 | 68 | 3 | GO:0071312 | |
| GeneOntologyBiologicalProcess | lipid biosynthetic process | LPIN1 CYP3A7 MBTPS1 PIK3C2B CYP3A4 PI4KA AGPAT1 PI4K2A DGKH ELOVL6 | 3.14e-04 | 813 | 68 | 10 | GO:0008610 |
| GeneOntologyBiologicalProcess | phosphatidic acid metabolic process | 3.34e-04 | 41 | 68 | 3 | GO:0046473 | |
| GeneOntologyBiologicalProcess | lipid hydroxylation | 3.80e-04 | 9 | 68 | 2 | GO:0002933 | |
| GeneOntologyBiologicalProcess | phospholipid metabolic process | 3.98e-04 | 410 | 68 | 7 | GO:0006644 | |
| GeneOntologyBiologicalProcess | glycerolipid metabolic process | 5.21e-04 | 429 | 68 | 7 | GO:0046486 | |
| GeneOntologyBiologicalProcess | L-amino acid metabolic process | 6.19e-04 | 208 | 68 | 5 | GO:0170033 | |
| GeneOntologyBiologicalProcess | oxidative demethylation | 6.92e-04 | 12 | 68 | 2 | GO:0070989 | |
| GeneOntologyBiologicalProcess | dense core granule cytoskeletal transport | 6.92e-04 | 12 | 68 | 2 | GO:0099519 | |
| GeneOntologyBiologicalProcess | spliceosomal snRNP assembly | 7.54e-04 | 54 | 68 | 3 | GO:0000387 | |
| GeneOntologyBiologicalProcess | modified amino acid metabolic process | 7.65e-04 | 218 | 68 | 5 | GO:0006575 | |
| GeneOntologyBiologicalProcess | amino acid metabolic process | 7.87e-04 | 332 | 68 | 6 | GO:0006520 | |
| GeneOntologyBiologicalProcess | cellular response to xenobiotic stimulus | 8.30e-04 | 222 | 68 | 5 | GO:0071466 | |
| GeneOntologyBiologicalProcess | dense core granule transport | 9.50e-04 | 14 | 68 | 2 | GO:1901950 | |
| GeneOntologyCellularComponent | U5 snRNP | 8.18e-05 | 25 | 71 | 3 | GO:0005682 | |
| GeneOntologyCellularComponent | pole plasm | 1.29e-04 | 29 | 71 | 3 | GO:0045495 | |
| GeneOntologyCellularComponent | germ plasm | 1.29e-04 | 29 | 71 | 3 | GO:0060293 | |
| GeneOntologyCellularComponent | P granule | 1.29e-04 | 29 | 71 | 3 | GO:0043186 | |
| GeneOntologyCellularComponent | U4 snRNP | 8.66e-04 | 13 | 71 | 2 | GO:0005687 | |
| Domain | DNase_TatD-rel_CS | 1.38e-05 | 2 | 70 | 2 | IPR018228 | |
| Domain | PI3/4_kinase_cat_dom | 3.95e-05 | 18 | 70 | 3 | IPR000403 | |
| Domain | PI3_PI4_kinase | 3.95e-05 | 18 | 70 | 3 | PF00454 | |
| Domain | PI3_4_KINASE_3 | 3.95e-05 | 18 | 70 | 3 | PS50290 | |
| Domain | PI3_4_KINASE_1 | 3.95e-05 | 18 | 70 | 3 | PS00915 | |
| Domain | PI3_4_KINASE_2 | 3.95e-05 | 18 | 70 | 3 | PS00916 | |
| Domain | TatD_DNase | 4.14e-05 | 3 | 70 | 2 | PF01026 | |
| Domain | TATD_2 | 4.14e-05 | 3 | 70 | 2 | PS01090 | |
| Domain | TATD_3 | 4.14e-05 | 3 | 70 | 2 | PS01091 | |
| Domain | TatD_family | 4.14e-05 | 3 | 70 | 2 | IPR001130 | |
| Domain | Cyt_P450_E_grp-II | 1.37e-04 | 5 | 70 | 2 | IPR002402 | |
| Domain | Cyt_P450_E_CYP3A | 2.06e-04 | 6 | 70 | 2 | IPR008072 | |
| Domain | Kinesin_assoc | 2.06e-04 | 6 | 70 | 2 | PF16183 | |
| Domain | Kinesin_assoc | 2.06e-04 | 6 | 70 | 2 | IPR032405 | |
| Domain | PI3Ka | 4.90e-04 | 9 | 70 | 2 | PF00613 | |
| Domain | - | 4.90e-04 | 9 | 70 | 2 | 1.25.40.70 | |
| Domain | PI3Ka | 4.90e-04 | 9 | 70 | 2 | SM00145 | |
| Domain | PIK_HELICAL | 6.11e-04 | 10 | 70 | 2 | PS51545 | |
| Domain | PI_Kinase | 6.11e-04 | 10 | 70 | 2 | IPR015433 | |
| Domain | PInositide-3_kin_accessory_dom | 6.11e-04 | 10 | 70 | 2 | IPR001263 | |
| Domain | SAM/pointed | 9.75e-04 | 117 | 70 | 4 | IPR013761 | |
| Domain | PI3/4_kinase_CS | 1.41e-03 | 15 | 70 | 2 | IPR018936 | |
| Domain | - | 1.61e-03 | 16 | 70 | 2 | 1.10.1070.11 | |
| Domain | PI3Kc | 1.61e-03 | 16 | 70 | 2 | SM00146 | |
| Domain | Metal_Hydrolase | 3.62e-03 | 24 | 70 | 2 | IPR032466 | |
| Domain | Cys-rich_flank_reg_C | 4.69e-03 | 90 | 70 | 3 | IPR000483 | |
| Domain | LRRCT | 4.69e-03 | 90 | 70 | 3 | SM00082 | |
| Domain | FHA | 4.91e-03 | 28 | 70 | 2 | SM00240 | |
| Domain | Ig_I-set | 5.64e-03 | 190 | 70 | 4 | IPR013098 | |
| Domain | I-set | 5.64e-03 | 190 | 70 | 4 | PF07679 | |
| Domain | LRRNT | 5.95e-03 | 98 | 70 | 3 | IPR000372 | |
| Domain | LRRNT | 5.95e-03 | 98 | 70 | 3 | SM00013 | |
| Domain | FHA_DOMAIN | 6.00e-03 | 31 | 70 | 2 | PS50006 | |
| Domain | FHA | 6.00e-03 | 31 | 70 | 2 | PF00498 | |
| Domain | LRRCT | 6.39e-03 | 32 | 70 | 2 | PF01463 | |
| Domain | - | 7.38e-03 | 106 | 70 | 3 | 1.10.150.50 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | BLM DNAH12 COL6A6 PIK3C2B P4HA1 USP9X ALDH1L1 HYDIN RGS12 RYR3 | 7.88e-08 | 497 | 72 | 10 | 36774506 |
| Pubmed | The crystal structure of the phosphatidylinositol 4-kinase IIα. | 4.23e-06 | 2 | 72 | 2 | 25168678 | |
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 28986474 | ||
| Pubmed | Differential regulation of CYP3A4 and CYP3A7 by dimethylsulfoxide in primary human hepatocytes. | 4.23e-06 | 2 | 72 | 2 | 15379787 | |
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 26772622 | ||
| Pubmed | Role of Chromatin Structural Changes in Regulating Human CYP3A Ontogeny. | 4.23e-06 | 2 | 72 | 2 | 26921389 | |
| Pubmed | Molecular mechanisms of polymorphic CYP3A7 expression in adult human liver and intestine. | 4.23e-06 | 2 | 72 | 2 | 11940601 | |
| Pubmed | Expression of CYP3A4 and CYP3A7 in Human Foetal Tissues and its Correlation with Nuclear Receptors. | 4.23e-06 | 2 | 72 | 2 | 25689036 | |
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 27349315 | ||
| Pubmed | Developmental regulation of CYP3A4 and CYP3A7 in Chinese Han population. | 4.23e-06 | 2 | 72 | 2 | 27727071 | |
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 12485945 | ||
| Pubmed | 9.77e-06 | 504 | 72 | 8 | 34432599 | ||
| Pubmed | Uridylation by TUT4/7 Restricts Retrotransposition of Human LINE-1s. | 1.27e-05 | 3 | 72 | 2 | 30122351 | |
| Pubmed | 1.27e-05 | 3 | 72 | 2 | 19801957 | ||
| Pubmed | Metabolic pathways of inhaled glucocorticoids by the CYP3A enzymes. | 1.27e-05 | 3 | 72 | 2 | 23143891 | |
| Pubmed | 1.27e-05 | 3 | 72 | 2 | 33866277 | ||
| Pubmed | 1.27e-05 | 3 | 72 | 2 | 20621111 | ||
| Pubmed | Contribution of three CYP3A isoforms to metabolism of R- and S-warfarin. | 1.27e-05 | 3 | 72 | 2 | 20615193 | |
| Pubmed | 1.27e-05 | 3 | 72 | 2 | 22277676 | ||
| Pubmed | Comparison of steroid hormone hydroxylation mediated by cytochrome P450 3A subfamilies. | 1.27e-05 | 3 | 72 | 2 | 32001245 | |
| Pubmed | 1.27e-05 | 3 | 72 | 2 | 32146629 | ||
| Pubmed | 1.27e-05 | 3 | 72 | 2 | 23404705 | ||
| Pubmed | 1.27e-05 | 3 | 72 | 2 | 19581584 | ||
| Pubmed | 1.27e-05 | 3 | 72 | 2 | 17582393 | ||
| Pubmed | 1.27e-05 | 3 | 72 | 2 | 20118548 | ||
| Pubmed | 1.27e-05 | 3 | 72 | 2 | 34688813 | ||
| Pubmed | Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism. | ZSWIM8 RIMKLB SARS2 ERG ASL AGPAT1 CTDP1 SMARCD3 LONRF3 POLK | 2.04e-05 | 925 | 72 | 10 | 28986522 |
| Pubmed | 2.53e-05 | 4 | 72 | 2 | 12594831 | ||
| Pubmed | 2.53e-05 | 4 | 72 | 2 | 20375060 | ||
| Pubmed | 2.53e-05 | 4 | 72 | 2 | 26238215 | ||
| Pubmed | 2.53e-05 | 4 | 72 | 2 | 28341829 | ||
| Pubmed | 2.53e-05 | 4 | 72 | 2 | 34689350 | ||
| Pubmed | 2.53e-05 | 4 | 72 | 2 | 18978522 | ||
| Pubmed | 2.69e-05 | 28 | 72 | 3 | 8944226 | ||
| Pubmed | 4.21e-05 | 5 | 72 | 2 | 24168324 | ||
| Pubmed | 4.21e-05 | 5 | 72 | 2 | 14559847 | ||
| Pubmed | Genomic organization of the human CYP3A locus: identification of a new, inducible CYP3A gene. | 4.21e-05 | 5 | 72 | 2 | 11266076 | |
| Pubmed | Stabilization of phosphatidylinositol 4-kinase type IIbeta by interaction with Hsp90. | 4.21e-05 | 5 | 72 | 2 | 21330372 | |
| Pubmed | 4.21e-05 | 5 | 72 | 2 | 11093772 | ||
| Pubmed | High-throughput analyses of hnRNP H1 dissects its multi-functional aspect. | RIMKLB LAMTOR4 PIK3C2B TATDN2 B4GALNT2 SMARCD3 DGKH COL25A1 TATDN1 KIF1C | 4.69e-05 | 1021 | 72 | 10 | 26760575 |
| Pubmed | 4.86e-05 | 34 | 72 | 3 | 18848646 | ||
| Pubmed | 6.16e-05 | 653 | 72 | 8 | 22586326 | ||
| Pubmed | The human cytochrome P450 3A locus. Gene evolution by capture of downstream exons. | 8.82e-05 | 7 | 72 | 2 | 11137287 | |
| Pubmed | 8.82e-05 | 7 | 72 | 2 | 19842932 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | BLM FBXL18 PI4KA RPS6 TAF1B TUT7 ASNS ADNP2 MTHFS MOV10 AAR2 | 1.01e-04 | 1353 | 72 | 11 | 29467282 |
| Pubmed | 1.17e-04 | 8 | 72 | 2 | 20147896 | ||
| Pubmed | HIV-1 capsids bind and exploit the kinesin-1 adaptor FEZ1 for inward movement to the nucleus. | 1.17e-04 | 8 | 72 | 2 | 25818806 | |
| Pubmed | 1.51e-04 | 9 | 72 | 2 | 17119116 | ||
| Pubmed | One-carbon metabolism gene polymorphisms and risk of non-Hodgkin lymphoma in Australia. | 1.88e-04 | 10 | 72 | 2 | 17891500 | |
| Pubmed | USP9X-mediated NRP1 deubiquitination promotes liver fibrosis by activating hepatic stellate cells. | 1.88e-04 | 10 | 72 | 2 | 36653359 | |
| Pubmed | 1.88e-04 | 10 | 72 | 2 | 12865317 | ||
| Pubmed | 2.42e-04 | 58 | 72 | 3 | 31067491 | ||
| Pubmed | 2.75e-04 | 12 | 72 | 2 | 15319333 | ||
| Pubmed | Sequence diversity and haplotype structure at the human CYP3A cluster. | 3.25e-04 | 13 | 72 | 2 | 16314882 | |
| Pubmed | 3.25e-04 | 13 | 72 | 2 | 19936946 | ||
| Pubmed | The ubiquitin ligase TRIM25 targets ERG for degradation in prostate cancer. | 3.78e-04 | 14 | 72 | 2 | 27626314 | |
| Pubmed | 4.03e-04 | 300 | 72 | 5 | 28561026 | ||
| Pubmed | Expression of the Neuronal tRNA n-Tr20 Regulates Synaptic Transmission and Seizure Susceptibility. | 4.36e-04 | 15 | 72 | 2 | 32853550 | |
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | 4.89e-04 | 313 | 72 | 5 | 38270169 | |
| Pubmed | 4.98e-04 | 16 | 72 | 2 | 29979702 | ||
| Pubmed | Targeting USP9X-AMPK Axis in ARID1A-Deficient Hepatocellular Carcinoma. | 4.98e-04 | 16 | 72 | 2 | 35390516 | |
| Pubmed | 5.47e-04 | 686 | 72 | 7 | 29987050 | ||
| Pubmed | 5.61e-04 | 689 | 72 | 7 | 36543142 | ||
| Pubmed | 5.63e-04 | 17 | 72 | 2 | 17496333 | ||
| Pubmed | 5.63e-04 | 17 | 72 | 2 | 19424794 | ||
| Pubmed | Endothelial deletion of Ino80 disrupts coronary angiogenesis and causes congenital heart disease. | 5.63e-04 | 17 | 72 | 2 | 29371594 | |
| Pubmed | Interferon regulatory factor 8 (IRF8) interacts with the B cell lymphoma 6 (BCL6) corepressor BCOR. | 5.63e-04 | 17 | 72 | 2 | 25331958 | |
| Pubmed | 6.72e-04 | 1168 | 72 | 9 | 19946888 | ||
| Pubmed | 6.77e-04 | 191 | 72 | 4 | 20195357 | ||
| Pubmed | 7.04e-04 | 193 | 72 | 4 | 19343046 | ||
| Pubmed | Molecular genetics of the human cytochrome P450 monooxygenase superfamily. | 7.84e-04 | 20 | 72 | 2 | 9890157 | |
| Pubmed | 7.96e-04 | 87 | 72 | 3 | 12465718 | ||
| Pubmed | 8.19e-04 | 201 | 72 | 4 | 23535732 | ||
| Pubmed | Shotgun sequencing of the human transcriptome with ORF expressed sequence tags. | 1.00e-03 | 552 | 72 | 6 | 10737800 | |
| Pubmed | Genome-wide association study of chronic periodontitis in a general German population. | 1.06e-03 | 96 | 72 | 3 | 24024966 | |
| Pubmed | 1.13e-03 | 24 | 72 | 2 | 17937387 | ||
| Pubmed | 1.19e-03 | 100 | 72 | 3 | 10048485 | ||
| Pubmed | Identification and classification of 16 new kinesin superfamily (KIF) proteins in mouse genome. | 1.23e-03 | 25 | 72 | 2 | 9275178 | |
| Pubmed | 1.33e-03 | 26 | 72 | 2 | 23435420 | ||
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | 1.36e-03 | 1038 | 72 | 8 | 26673895 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | 1.38e-03 | 588 | 72 | 6 | 38580884 | |
| Pubmed | C1orf106 is a colitis risk gene that regulates stability of epithelial adherens junctions. | 1.43e-03 | 27 | 72 | 2 | 29420262 | |
| Pubmed | 1.64e-03 | 411 | 72 | 5 | 36652389 | ||
| Pubmed | Integrating genetic and network analysis to characterize genes related to mouse weight. | 1.65e-03 | 29 | 72 | 2 | 16934000 | |
| Pubmed | 1.65e-03 | 29 | 72 | 2 | 19048631 | ||
| Pubmed | TopBP1 controls BLM protein level to maintain genome stability. | 1.65e-03 | 29 | 72 | 2 | 24239288 | |
| Pubmed | 1.71e-03 | 1335 | 72 | 9 | 29229926 | ||
| Pubmed | 1.72e-03 | 415 | 72 | 5 | 16385451 | ||
| Pubmed | Large-scale identification of human genes implicated in epidermal barrier function. | 1.77e-03 | 30 | 72 | 2 | 17562024 | |
| Pubmed | 1.77e-03 | 30 | 72 | 2 | 20529763 | ||
| Pubmed | 1.82e-03 | 116 | 72 | 3 | 30804394 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | 2.01e-03 | 1105 | 72 | 8 | 35748872 | |
| Interaction | FBXO22 interactions | BLM DNAH12 COL6A6 PIK3C2B P4HA1 USP9X ALDH1L1 HYDIN RGS12 RYR3 AAR2 | 2.06e-06 | 540 | 69 | 11 | int:FBXO22 |
| GeneFamily | Cytochrome P450 family 3 | 1.91e-04 | 8 | 48 | 2 | 1002 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 8.69e-04 | 161 | 48 | 4 | 593 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.80e-06 | 158 | 72 | 5 | 9f58428f70d1427b20122c5c1cc7bf521d0f4832 | |
| ToppCell | droplet-Heart-4Chambers-21m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-05 | 185 | 72 | 5 | bb5a4cf93534b9bcd0923f314c389d571e91e7f8 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.42e-05 | 190 | 72 | 5 | 656483751e4bf137e4e4bfb2a03a478a8f7fcb63 | |
| ToppCell | background-Endothelial_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.61e-05 | 195 | 72 | 5 | c7d60dabfc7cb310e002cab10003dadfcc34fe33 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.65e-05 | 196 | 72 | 5 | 22767bcf0095d9eb0cbed7cdc74e4d32d9357e1b | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.65e-05 | 196 | 72 | 5 | adee900dcd16dbaba15c58bdcace09ba20214950 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.73e-05 | 198 | 72 | 5 | 07701c73137947ed4a27e225975329235bbb8734 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.73e-05 | 198 | 72 | 5 | fa84bf8533d1b91d2c2bcf06b710670605072b89 | |
| Disease | tacrolimus measurement | 3.22e-05 | 4 | 69 | 2 | EFO_0008458 | |
| Disease | estrone conjugate measurement | 3.22e-05 | 4 | 69 | 2 | EFO_0007971 | |
| Disease | tauro-beta-muricholate measurement | 5.36e-05 | 5 | 69 | 2 | EFO_0800213 | |
| Disease | glyco-beta-muricholate measurement | 5.36e-05 | 5 | 69 | 2 | EFO_0800569 | |
| Disease | dehydroisoandrosterone sulfate DHEA-S measurement | 8.03e-05 | 6 | 69 | 2 | EFO_0021119 | |
| Disease | androstenediol (3beta,17beta) monosulfate (1) measurement | 8.03e-05 | 6 | 69 | 2 | EFO_0800294 | |
| Disease | X-24574 measurement | 1.12e-04 | 7 | 69 | 2 | EFO_0800897 | |
| Disease | androstenediol (3beta,17beta) disulfate (1) measurement | 1.92e-04 | 9 | 69 | 2 | EFO_0800278 | |
| Disease | 4-androsten-3alpha,17alpha-diol monosulfate (3) measurement | 2.40e-04 | 10 | 69 | 2 | EFO_0022090 | |
| Disease | 5alpha-androstan-3beta,17alpha-diol disulfate measurement | 2.40e-04 | 10 | 69 | 2 | EFO_0800289 | |
| Disease | DNA repair protein RAD51 homolog 4 measurement | 2.92e-04 | 11 | 69 | 2 | EFO_0801531 | |
| Disease | androstenediol (3beta,17beta) monosulfate (2) measurement | 2.92e-04 | 11 | 69 | 2 | EFO_0800295 | |
| Disease | nervous system disease (implicated_via_orthology) | 3.50e-04 | 12 | 69 | 2 | DOID:863 (implicated_via_orthology) | |
| Disease | 5alpha-androstan-3beta,17beta-diol monosulfate (2) measurement | 3.50e-04 | 12 | 69 | 2 | EFO_0800291 | |
| Disease | androstenediol (3alpha, 17alpha) monosulfate (3) measurement | 4.13e-04 | 13 | 69 | 2 | EFO_0800293 | |
| Disease | 5alpha-pregnan-3beta,20beta-diol monosulfate (1) measurement | 4.13e-04 | 13 | 69 | 2 | EFO_0800284 | |
| Disease | X-21470 measurement | 4.82e-04 | 14 | 69 | 2 | EFO_0800817 | |
| Disease | 5alpha-androstan-3alpha,17alpha-diol monosulfate measurement | 4.82e-04 | 14 | 69 | 2 | EFO_0800283 | |
| Disease | 16a-hydroxy DHEA 3-sulfate measurement | 5.55e-04 | 15 | 69 | 2 | EFO_0800301 | |
| Disease | X-21410 measurement | 6.33e-04 | 16 | 69 | 2 | EFO_0800813 | |
| Disease | andro steroid monosulfate C19H28O6S (1) measurement | 6.33e-04 | 16 | 69 | 2 | EFO_0800305 | |
| Disease | 5alpha-androstan-3alpha,17beta-diol monosulfate (1) measurement | 8.05e-04 | 18 | 69 | 2 | EFO_0800288 | |
| Disease | metabolonic lactone sulfate measurement | 8.98e-04 | 19 | 69 | 2 | EFO_0800659 | |
| Disease | etiocholanolone glucuronide measurement | 8.98e-04 | 19 | 69 | 2 | EFO_0800362 | |
| Disease | androsterone glucuronide measurement | 9.96e-04 | 20 | 69 | 2 | EFO_0800317 | |
| Disease | X-24947 measurement | 1.21e-03 | 22 | 69 | 2 | EFO_0800910 | |
| Disease | 5alpha-androstan-3beta,17beta-diol disulfate measurement | 1.21e-03 | 22 | 69 | 2 | EFO_0021115 | |
| Disease | epiandrosterone sulfate measurement | 1.56e-03 | 25 | 69 | 2 | EFO_0021120 | |
| Disease | Epileptic encephalopathy | 2.25e-03 | 30 | 69 | 2 | C0543888 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GFHRLAVVDPLFGMQ | 46 | P08243 | |
| NKGIFHFQLGRGEPM | 206 | Q9Y5B0 | |
| PDGHTFMQAGFRKAI | 146 | A6NF34 | |
| LDNGFAMFHKVRVPR | 256 | O15254 | |
| NGACLHKRMGFFQPL | 446 | Q8NHY0 | |
| PRLMHARNTGGAAFI | 216 | P11308 | |
| VGPRMGFFLSLHQRG | 71 | Q9Y312 | |
| AMFRFGQAVTRHGKI | 96 | Q9NR16 | |
| QPKVVGRHFRMFHAP | 116 | Q6IQ32 | |
| GRHFRMFHAPVRKVQ | 121 | Q6IQ32 | |
| HFFIGNRKVPEAMGL | 476 | Q8IWB1 | |
| HAQIHFGRVFMKPGL | 591 | Q9NQX3 | |
| LIFMPGLGFDKHGNR | 131 | P49914 | |
| MFKGEIFHRNHRSPV | 246 | P18428 | |
| RRLPGVNMFEQGHGK | 451 | Q14703 | |
| SFMGTFGKALRRPHL | 1036 | Q6UXM1 | |
| GMPFRQAHEASGKAV | 381 | P04424 | |
| VFTNRRPFGPVGFMK | 101 | P08684 | |
| KLHYFNGRGRMEPIR | 6 | Q16772 | |
| QGPRMVFPKINHGFL | 161 | Q9BXS0 | |
| VRHGFMLVGEPFAAK | 1526 | Q6ZR08 | |
| GHVQAGIFKPRFAMR | 156 | A6NC86 | |
| KGSMNRHVAAIGPRF | 1336 | P42356 | |
| RIVMGKNHVFRFNHP | 586 | O43896 | |
| RGHEMFVINRSKPLF | 466 | Q50LG9 | |
| GNLQCSPFHVRFGKM | 41 | Q14693 | |
| SPFHVRFGKMGVLRS | 46 | Q14693 | |
| MNGGPHLGLRLFQKF | 366 | Q86XP1 | |
| FGQHSMRRVIVQPGK | 466 | Q9P2V4 | |
| RFLGHAQMFGNIKRD | 1216 | O00750 | |
| FDRGQFHKQIAVMRG | 411 | Q9BTU6 | |
| GFVGHPVNAFKLMKR | 76 | P13674 | |
| AAFIFGGRHLMNKRA | 41 | Q9H5J4 | |
| RIKGEGMGPKIHFNF | 451 | Q4G0P3 | |
| GMRNIKHVGPSGRFT | 1096 | P54132 | |
| VAMIFFRVHEPGNGF | 156 | P24387 | |
| KRRPDIFHALKMGNF | 291 | Q68DC2 | |
| IRMPAFFNGIFGHKP | 231 | Q6GMR7 | |
| CGFRLHRGMNVPFKR | 51 | Q0VGL1 | |
| HRGMNVPFKRLSVVF | 56 | Q0VGL1 | |
| RMGNKGGVAIRFQFH | 456 | P32019 | |
| VFTNRRPFGPVGFMK | 101 | P24462 | |
| RSMPLGARILFHGVF | 11 | Q9GZY4 | |
| ATVVQGFPMFKRGRC | 16 | O14625 | |
| GRSPMLNHLRKNFGF | 86 | A6NMZ7 | |
| GNRIIMGKSHVFRFN | 581 | Q12756 | |
| NKARAPAFSMGIRHS | 251 | Q3SX64 | |
| ARVLHMVGDKPVFSF | 186 | Q9NP81 | |
| MPFVKGLENRHNYGR | 41 | A4D263 | |
| PMSRAFRGKHLSFVV | 876 | Q93008 | |
| FPMKQGVLTHGRVRL | 61 | P62753 | |
| PMFRGIYRGVQKHQD | 16 | Q6P1N9 | |
| QALRHPKAVAFGEMG | 581 | Q93075 | |
| RQGFPIIFHGVMGKD | 771 | Q9HCE1 | |
| HGRFQTAQEKRAFMG | 376 | Q92901 | |
| HFPEQMKLYGRDRGI | 251 | Q53T94 | |
| MHAVPRGFGKKVRVG | 441 | Q96ME1 | |
| SKLFEFLVHGVRPGM | 16 | Q6STE5 | |
| AALRPMGHFTVLGKA | 41 | P0CW24 | |
| RTVRMPHQLFIGGEF | 416 | O75891 | |
| AFGMQSIFGPHRNVR | 606 | O14924 | |
| AGLMAGRPAFASHRK | 291 | O15375 | |
| HVQGILRGFDPFMNL | 26 | P62308 | |
| FTMRKHGGEKGVPFR | 196 | Q12800 | |
| RNHNGSMLPFKRGAF | 181 | Q99943 | |
| FSAGVKVRFLMGGRH | 781 | Q15413 | |
| HVQGILRGFDPFMNL | 26 | A8MWD9 | |
| GFLHRDIKPSNFAMG | 136 | Q6IQ55 | |
| FGVRAAMPGFIAKRL | 146 | Q9UBT6 | |
| LEFPMVVKNTRGHRG | 151 | Q9ULI2 | |
| FRMRAVKDPLQIGFH | 141 | A7E2V4 | |
| RKRAHIGVIPHFFMA | 231 | Q6NXT6 | |
| MKAFINGRRVFGIPV | 1301 | Q5VYS8 | |
| FSSPGNLRRHMVVKG | 226 | P15621 | |
| FPGEGRVVGRQLMHK | 301 | Q5T124 | |
| LRPMGFKAHFRKAQA | 306 | Q496Y0 | |
| IFRVRAVNKMGIGFP | 581 | P52179 |